San Francisco, United States
Aluna is a health care startup founded in 2016 that aims to revolutionize the way chronic respiratory conditions, such as asthma, are managed. With the slogan "Breathe Easier," the company developed a spirometer device and mobile app that utilizes machine learning to provide daily measurements and insights for users to better understand and take control of their lung health.
The startup recently secured a significant $15.30M Series B investment on January 31, 2023, with reputable investors such as SOSV, indiebio, Rho Capital Partners, Matrix, and Warner Carr. This injection of funding underscores the market's confidence in Aluna's disruptive solution and indicates a promising trajectory for the company's future growth and development.
Aluna's innovative approach to respiratory health management, combined with substantial backing from key investors, positions the company as a compelling player in the health care industry. As the demand for personalized health technology continues to soar, Aluna's unique offering and strategic partnerships set the stage for potential market leadership and significant value creation in the coming years.
